Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2001 | Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen | Hung C.-F.; WEN-FANG CHENG ; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. | Cancer Research | 0 | ||
2002 | Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion | WEN-FANG CHENG ; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. | Human Gene Therapy | 115 | 103 | |
2014 | Circulating IGF system and treatment outcome in epithelial ovarian cancer | Huang Y.-F.; WEN-FANG CHENG ; Wu Y.-P.; Cheng Y.-M.; Hsu K.-F.; Chou C.-Y. | Endocrine-Related Cancer | 39 | 36 | |
2001 | Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand | Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG ; Chai C.-Y.; He L.; Ling M.; Wu T.-C. | Cancer Research | 0 | ||
2001 | Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen | WEN-FANG CHENG ; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. | Journal of Virology | 79 | 64 | |
2001 | Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene | WEN-FANG CHENG ; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C. | Journal of Immunology | 66 | 56 | |
2001 | Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments | WEN-FANG CHENG ; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C. | Human Gene Therapy | 67 | 61 | |
2001 | Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen | Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG ; He L.; Slater L.A.; Ling M.; Wu T.-C. | Gene Therapy | 115 | 96 | |
2014 | Impact of management on the prognosis of pure uterine papillary serous cancer - A Taiwanese Gynecologic Oncology Group (TGOG) study | Huang C.-Y.; Tang Y.-H.; YING-CHENG CHIANG ; Wang K.-L.; Fu H.-C.; Ke Y.-M.; Lau H.-Y.; Hsu K.-F.; Wu C.-H.; WEN-FANG CHENG | Gynecologic Oncology | 29 | 26 | |
2001 | Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen | Hung C.-F.; WEN-FANG CHENG ; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. | Journal of Immunology | 131 | 114 | |
2014 | Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group study | Hsu K.-F.; Chou H.-H.; Huang C.-Y.; Fu H.-C.; Chiang A.-J.; Tsai H.-W.; Chen J.-R.; WEN-FANG CHENG ; Ke Y.-M.; Chang C.-C.; Chen T.-H.; Lin S.-H.; Ho C.-M. | Gynecologic Oncology | 15 | 15 | |
2012 | Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: A retrospective observational study of Taiwanese Gynecologic Oncology Group | YU-LI CHEN ; Wang K.-L.; Chen M.-Y.; Yu M.-H.; Wu C.-H.; Ke Y.-M.; Chen Y.-J.; Chang Y.-Y.; Hsu K.-F.; Yen M.-S. | Journal of Gynecologic Oncology | 19 | 17 | |
2018 | Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: A Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study | Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG ; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S. | Journal of Gynecologic Oncology | 7 | 6 | |
2001 | Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen | WEN-FANG CHENG ; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C. | Journal of Clinical Investigation | 250 | 0 |